Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
GuardantOMNI
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Guardant Health
Type:
Laboratory Developed Test
Related tests:
‹
Guardant360® CDx (54)
Guardant360 TissueNext™ (2)
Guardant360 Response™ (1)
GUARDANT SHIELD
GuardantINFINITY™
GuardantREVEAL
Lunar-2
Guardant360® CDx (54)
Guardant360 TissueNext™ (2)
Guardant360 Response™ (1)
GUARDANT SHIELD
GuardantINFINITY™
GuardantREVEAL
Lunar-2
›
Details
Evidence
News
Search handles
@RenoHemonc
Search handles
@RenoHemonc
Filter by
Latest
over1year
🔥Genomic mechanisms of acquired resistance in mBRAF V600E #colorectalcance in BEACON🔥at EMSO22 by @skopetz ✅320 pts -> ctDNA GuardantOMNI 👉Doublet: mutations in RAS-MEK signaling 👉Triplete: enhanced receptor signaling @myESMO @OncoAlert ()
over 1 year ago
Clinical • Circulating tumor DNA
|
BRAF V600E • BRAF V600 • RAS mutation
|
GuardantOMNI
almost5years
“@pashtoonkasi Rizvi- “ With the GuardantOMNI assay, Rizvi said TMB has been measured within 85% accuracy, with as low as 0.5% maximum somatic mutation allele fraction in a blood-based assay.“ Interesting..“ (@RenoHemonc)
almost 5 years ago
GuardantOMNI
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login